Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory B-Cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06334991
What this trial is testing

Study for Participants With Relapsed/Refractory Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma Refractory/ Relapsed
ImmunityBio, Inc. 20
Early research (Phase 1)UnknownNCT03881774
What this trial is testing

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Who this might be right for
RefractoryRelapsedB Cell Lymphoma+1 more
Henan Cancer Hospital 20
Early research (Phase 1)Looking for participantsNCT06034275
What this trial is testing

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaB-cell Acute Lymphoblastic LeukemiaHigh-risk Myelodysplastic Syndrome
Vincerx Pharma, Inc. 36
Testing effectiveness (Phase 2)Ended earlyNCT00005950
What this trial is testing

506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma

Who this might be right for
Angioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+7 more
National Cancer Institute (NCI) 111
Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Testing effectiveness (Phase 2)UnknownNCT04431089
What this trial is testing

Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma

Who this might be right for
Follicular Lymphoma(FL)Marginal Zone Lymphoma(MZL)
Nanjing Sanhome Pharmaceutical, Co., Ltd. 122
Testing effectiveness (Phase 2)UnknownNCT06033820
What this trial is testing

Zanubrutinib+Lenalidomide+R-ICE in Relapsed/Refractory DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma RecurrentDiffuse Large B Cell Lymphoma Refractory
RenJi Hospital 20
Post-approval studies (Phase 4)UnknownNCT03579082
What this trial is testing

A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Mingzhi Zhang 60
Testing effectiveness (Phase 2)Study completedNCT03458260
What this trial is testing

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Aggressive Non-Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 74
Large-scale testing (Phase 3)Active Not RecruitingNCT06929624
What this trial is testing

Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 282
Testing effectiveness (Phase 2)Ended earlyNCT01282476
What this trial is testing

Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Massachusetts General Hospital 18
Early research (Phase 1)Ended earlyNCT06210243
What this trial is testing

C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, B-CellCAR-T
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 2
Early research (Phase 1)UnknownNCT04887025
What this trial is testing

Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Large-scale testing (Phase 3)Study completedNCT00005805
What this trial is testing

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+5 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Testing effectiveness (Phase 2)WithdrawnNCT01649622
What this trial is testing

Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00003395
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00873457
What this trial is testing

Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Daphne Friedman 16
Testing effectiveness (Phase 2)Ended earlyNCT00848328
What this trial is testing

Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
University of California, Davis 30
Early research (Phase 1)Looking for participantsNCT06703892
What this trial is testing

Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies

Who this might be right for
Diffuse Large B Cell Lymphoma RelapsedDiffuse Large B Cell Lymphoma RefractoryFollicular Lymphoma ( FL)+3 more
GenomeFrontier Therapeutics TW Co., Ltd. 18
Next Page